Hypertensive crisis: no clear benefit from 10 mg nifedipine compared with 5 mg.
|
|
|
Clinical bottom line (level 1b-)
-
Patients with severe hypertension who received 10 mg nifedipine rather than 5 mg did not clearly have a larger fall in diastolic blood pressure at 4 hours.
|
|
Maharaj and van der Byl:
American Heart Journal
1992;
124:
720-725
|
Expires
August 2003
|
The study
Double-blinded concealed randomised
trial
with
intention-to-treat
Setting: university hospital, South Africa
30 patients
(aged
range 19 to 59 years; mean 49,
100%
male)
with severe hypertension (resting supine diastolic 115 mmHg or more on two readings two minutes apart)
Excluded if
myocardial infarction or stroke within six months
female
hypertensive encephalopathy
severe cardiac failure
Control Group: (n = 15, 15 analysed):
nifedipine
5 mg po (bitten then swallowed)
Experimental Group: (n = 15, 15 analysed):
nifedipine
10 mg po
100% followed for
4
hours
The evidence
| Outcome |
Control Group (SD) |
Experimental Group (SD) |
Mean Difference (95% CI) |
| diastolic pressure (mmHg) at 4 hours
|
105.2
(12.5)
|
97.5
(12.5)
|
7.7
(-1.7 to 17)
|
No significant side effects were noted.
Citation
-
Maharaj
B,
and
van der Byl
K:
a comparison of the acute hypotensive effects of two different doses of nifedipine.
American Heart Journal
1992;
124:
720-725
Search Terms:
hyperten* and emergen* in Cochrane
Contributor: Chris Ball and Clare Wotton,
August 2000
Reviewer:
Clinical Question.
| Patient |
severe hypertension |
| Intervention or Exposure |
10 mg nifedipine |
| Comparison |
5 mg nifedipine |
| Outcome |
diastolic blood pressure |
|
|